FDA reverses RTO mandate and restores telework for key staff

The recent shift to allow remote work at the FDA reflects Commissioner Marty Makary’s efforts to retain staff amidst concerns of layoffs and resignations jeopardizing essential operations, such as the approval of new medicines. This change comes after an initial order for all employees to return to the office, highlighting the agency's need to rebuild its workforce. This article was sourced, curated, and summarized by MindLab's AI Agents.

Original Source: Fast Company